Regulations.gov document
Reference 39 - Goldberg AB, Fulcher IR, Fortin J, Hofer RK, Cottrill A, Dthier D, et al…
Supporting & Related Material · FDA-2022-P-2425 · posted Apr 25, 2024
Key facts
| Document ID | FDA-2022-P-2425-0042 |
|---|---|
| Title | Reference 39 - Goldberg AB, Fulcher IR, Fortin J, Hofer RK, Cottrill A, Dthier D, et al. Mifepristone and misoprostol for undesired pregnancy of unknown location. Obstet Gynecol 2022;139(5):771-780. |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2022-P-2425 |
| Posted | Apr 25, 2024 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: